Loading...
•
Mar 31
Cigna Q1 2025 Earnings Report
The Cigna Group reported strong Q1 2025 results with a significant increase in revenues and a return to profitability.
Key Takeaways
The Cigna Group delivered robust financial results in Q1 2025, with total revenues growing 14% year-over-year to $65.5 billion and net income reaching $1.3 billion. Adjusted income from operations was $1.8 billion, highlighting strong performance across Evernorth Health Services and Cigna Healthcare segments.
Total revenues rose 14% year-over-year to $65.5 billion, driven by strong growth in pharmacy services.
Net income reached $1.3 billion, reversing a net loss of $0.3 billion in Q1 2024.
Adjusted income from operations was $1.8 billion or $6.74 per share.
The company raised its full-year 2025 outlook to at least $29.60 adjusted income per share.
Cigna
Cigna
Cigna Revenue by Segment
Revenue by Segment
Pharmacy Benefit Services Revenue
CapyFin.comSpecialty and Care Services Revenue
CapyFin.comCigna Healthcare Revenue
CapyFin.com Forward Guidance
Cigna raised its 2025 outlook, expecting at least $29.60 in adjusted income per share, reflecting confidence in strong segment performance and capital deployment.
Positive Outlook
- Raised 2025 adjusted EPS guidance to at least $29.60.
- Expected Evernorth adjusted income from operations to exceed $7.2 billion.
- Expected Cigna Healthcare adjusted income from operations to exceed $4.125 billion.
- Continued share repurchases projected to support EPS growth.
- Anticipated strong performance in pharmacy and specialty services.
Challenges Ahead
- Higher expected medical costs contributing to elevated MCR.
- Impact of HCSC divestiture may reduce customer base in near term.
- Strategic investments may compress near-term operating margins.
- Lower net investment income compared to prior year.
- Macroeconomic and regulatory uncertainties could affect growth targets.